Boehringer Ingelheim Licenses GeneGo's MetaCore | GenomeWeb
NEW YORK (GenomeWeb News) - GeneGo said today that Boehringer Ingelheim has licensed its MetaCore data-mining software suite.
 
Boehringer Ingelheim will use the software primarily for toxicogenomics research, GeneGo said.
 
MetaCore is based on a manually curated database of human biology, diseases, toxicology, and bioactive chemistry.
 
Financial terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.